Personal Account
Maravai LifeSciences

Maravai LifeSciences

Life sciences company providing critical products to enable the development of drug therapies

Company website
Foundation year

2014

Close date

12/20/2020

Profitability

7.67%

About

Total Funding 

$1B

Maravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm. Maravai’s mission is to build a transformative life sciences products company by acquiring outstanding businesses and accelerating their growth. They do this through direct cash investments in their existing operations, by acquiring complementary businesses or product lines and by contributing our proven operating expertise.

Number of employees

51-100

Headquarters

San Diego, California, United States


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.